Most Recent
Danish pharmaceutical giant Lundbeck secured $51.7 million in settlements to end infringement litigation with three generic makers over its patent for the top-selling Lexapro, the company has revealed.
Otsuka Pharmaceuticals and Bristol Myers-Squibb can retain their defences in an ongoing patent dispute over antipsychotic drug Abilify, after the Federal Court dismissed a strike out bid by the Commonwealth of Australia over the allegedly "inconsistent" pleadings.
Hytera has challenged Motorola's claims that it owns the copyright for the digital radio source code that's at the centre of copyright allegations against the Chinese radio maker.
A damages battle in an infringement case over two patents for the ubiquitous plastic produce containers found in grocery stores across Australia is over, with the fight settling ahead of a hearing.
Railway technology company Wavetrain Systems has dropped its bid for a court order barring a competitor started by its former CEO from making allegedly false claims about its patented rail safety devices to clients.
The Full Court has denied a request by Sanofi that it review a judge's refusal to block Alphapharm from listing its Semglee insulin injector pen on the PBS, calling the pharmaceutical giant's appeal "misconceived".
New Zealand-based medical device maker Fisher & Paykel and US-based ResMed have agreed to resolve all disputes between them over patents for devices used to treat sleep apnea.
Property listing rivals REA Group and Domain have settled a trade mark lawsuit over an agreement between Domain and the owner of US website realestate.com to redirect Australian traffic to Domain's website.
Maurice Blackburn has persuaded a judge to lift a temporary injunction that blocked the law firm from going ahead with plans to unveil a replica of the iconic New York statue, Fearless Girl, at Melbourne's Federation Square for International Women's Day.
The Full Federal Court will issue its judgment Friday in French pharmaceutical giant Sanofi's challenge to a judge's refusal to block Alphapharm from listing an insulin injector pen on the PBS, just two weeks after the court heard arguments in the appeal.